Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
1.049
-0.061 (-5.50%)
At close: Aug 14, 2026, 4:00 PM EDT
1.049
0.00 (0.04%)
After-hours: Aug 14, 2026, 7:42 PM EDT
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $4.18 million as of August 14, 2026. Its market cap has decreased by -2.44% in one year.
Market Cap
4.18M
Enterprise Value
-6.56M
1-Year Change
-2.44%
Ranking
Category
Stock Price
$1.05
ChartMarket Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.51M to $4.18M, a decrease of -95.38%. That is a compound annual growth rate of -41.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 4.18M | -11.81% |
| Dec 31, 2025 | 4.74M | 22.99% |
| Dec 31, 2024 | 3.85M | 22.21% |
| Dec 29, 2023 | 3.15M | -29.09% |
| Dec 30, 2022 | 4.45M | -93.24% |
| Dec 31, 2021 | 65.80M | -29.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ernexa Therapeutics | 5.16M |
| Liminatus Pharma | 4.87M |
| Alaunos Therapeutics | 4.84M |
| Mustang Bio | 4.59M |
| Creative Medical Technology Holdings | 4.44M |
| Aptevo Therapeutics | 4.36M |
| PMGC Holdings | 4.09M |
| Silo Pharma | 3.88M |